The relationship of opium addiction with coronary artery disease

International Journal of Preventive Medicine

Volumn 1, Issue 3, 2010, Pages 182-186

  Masoomi, Mohammad ^a   Arash Ramezani, Mohammad ^b   Karimzadeh, Hadi ^c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NONE

Author keywords

Angiography; Coronary artery disease; Opium; Risk factor

Indexed keywords

OPIATE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; RISK ASSESSMENT; SELF REPORT;

EID: 79952055287     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001; 89(2): 123-37.
2. Peart JN, Gross ER, Gross GJ. Opioid-induced preconditioning: recent advances and future perspectives. Vascul Pharmacol 2005; 42(5-6): 211-18.
3. Romano MA, Seymour EM, Berry JA, McNish RA, Bolling SF. Relative contribution of endogenous opioids to myocardial ischemic tolerance. J Surg Res 2004; 118(1): 32-7.
4. Valtchanova-Matchouganska A, Ojewole JA. Mechanisms of opioid delta (delta) and kappa (kappa) receptors' cardioprotection in ischaemic preconditioning in a rat model of myocardial infarction. Cardiovasc J S Afr 2003; 14(2): 73-80.
5. Okubo S, Tanabe Y, Takeda K, Kitayama M, Kanemitsu S, Kukreja RC, et al. Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of delta-opioid receptor. Am J Physiol Heart Circ Physiol 2004; 287(4): H1786-H1791.
6. Bjornaas MA, Bekken AS, Ojlert A, Haldorsen T, Jacobsen D, Rostrup M, et al. A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo. BMC Psychiatry 2008; 8: 8.
7. National policy and strategies about prevention and control of addiction. 2005. Tehran, Iran: Headquarter against opiate abuse and smuggled.
8. Rahimimovaghar A. Guideline for prevention and treatment of addiction. Tehran: Prevention of Vice Cultural Welfare Organization, 1997.
9. Ziaaddini H, Ziaaddini MR. The household survey of drug abuse in Kerman, Iran. J Applied Sci 2005; 5: 380-2.
10. Azimzade-Sarwar B, Yousefzade GH, Narooey S. A case-control study of effect of opium addiction on myocardial infarction. American Journal of Applied Sciences 2005; 2(7): 1134-5.
11. Sadeghian S, Darvish S, Davoodi G, Salarifar M, Mahmoodian M, Fallah N, et al. The association of opium with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2007; 14(5): 715-17.
12. Marmor M, Penn A, Widmer K, Levin RI, Maslansky R. Coronary artery disease and opioid use. Am J Cardiol 2004; 93(10): 1295-1297.
13. Abdollahi MH, Forouzan SK, Zahreh S. Demographic characteristics of opioid addiction in patients undergoing Coronary Artery Bypass Graft. Tehran Univ Med J 2007; 64(10): 54-9.
14. Sadr Bafghi SM, Rafie M, Bahadorzadeh L, Namayeh SM, Soltan MH, Motafaker M. Is opium addiction a risk factor for acute myocardial infarction? Acta Medica Iranica 2005; 43(3): 218-22.
15. Hamzehee Moghadam A, Ahmadi Mousavi SMR, Khademizadeh K. The relationship between opium dependency and stroke. J Kerman Univ Med Sci 2006; 13(4): 203-8.
16. Aitchison KA, Baxter GF, Awan MM, Smith RM, Yellon DM, Opie LH. Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Basic Res Cardiol 2000; 95(1): 1-10.
17. Coles JA, Jr, Sigg DC, Iaizzo PA. Role of kappaopioid receptor activation in pharmacological preconditioning of swine. Am J Physiol Heart Circ Physiol 2003; 284(6): H2091-H2099.
18. Fatemi SS, Hasanzadeh M, Arghami A, Sargolzaee MR. Lipid Profile Comparison between Opium Addicts and Non-Addicts. The Journal of Tehran University Heart Center 2008; 3(3): 169-72.
19. Asgary S, Sarrafzadegan N, Naderi GA, Rozbehani R. Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter? Lipids Health Dis 2008; 7: 42.
20. Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M. Effects of opium addiction on some serum factors in addicts with noninsulin- dependent diabetes mellitus. Addict Biol 2004; 9(1): 53-8.